Bicine

CAS No. 150-25-4

Bicine( N,N-Bis(2-hydroxyethyl)glycine | Diethylolglycine | Diethanol glycine | Dihydroxyethylglycine )

Catalog No. M27533 CAS No. 150-25-4

Bicine is an organic compound used as a biological buffer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 42 In Stock
50MG 72 In Stock
100MG 115 In Stock
200MG 174 In Stock
500MG 293 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bicine
  • Note
    Research use only, not for human use.
  • Brief Description
    Bicine is an organic compound used as a biological buffer.
  • Description
    Bicine is an organic compound used as a biological buffer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N,N-Bis(2-hydroxyethyl)glycine | Diethylolglycine | Diethanol glycine | Dihydroxyethylglycine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    150-25-4
  • Formula Weight
    163.173
  • Molecular Formula
    C6H13NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 166.67 mg/mL (1021.45 m)
  • SMILES
    OCCN(CCO)CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jeon JS, et al. Preparative purification of plasmin activity stimulating phenolic derivatives from Gastrodia elata using centrifugal partition chromatography. Biomed Chromatogr. 2016 Jun;30(6):976-82.
molnova catalog
related products
  • PAR-2 (1-6) (mouse, ...

    PAR-2 (1-6) (mouse, rat)

  • PACMA 31

    PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.

  • Methylswertianin

    Methylswertianin is an active constituent in Swertia punicea Hemsl, with anti-diabetic effect. Methylswertianincan abates type-2 diabetes, likely via the improvement of insulin resistance (IR).